The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Boehringer Ingelheim; Pfizer
Research Funding - Taipei Veterans General Hospital
Characteristics, treatment patterns, and prognostic factors in small cell lung cancer transformation of advanced non-small cell lung cancer with epidermal growth factor receptor mutation after tyrosine kinase inhibitor therapy.
 
Ying-Ting Liao
Research Funding - Taipei Veterans General Hospital
 
Chi-Lu Chiang
Honoraria - AstraZeneca; Boehringer Ingelheim; Pfizer; Roche
Research Funding - Taipei Veterans General Hospital
 
Ruei-Lin Sun
No Relationships to Disclose
 
Yi-chen Yeh
Research Funding - Taipei Veterans General Hospital
 
Hsu-Ching Huang
No Relationships to Disclose
 
Chia-I Shen
Honoraria - Boehringer Ingelheim; Pfizer
Research Funding - Taipei Veterans General Hospital
 
Yen-Han Tseng
Research Funding - Taipei Veterans General Hospital
 
Yung-Hung Luo
No Relationships to Disclose
 
Yuh-Min Chen
No Relationships to Disclose
 
Jacqueline Whang-Peng
No Relationships to Disclose